Affiliation:
1. Center for Biological Defense, College of Public Health, University of South Florida, Tampa, Florida
2. Florida Department of Health, Bureau of Laboratories, Tampa, Florida
3. Department of Botany and Microbiology, University of Oklahoma, Norman, Oklahoma
Abstract
ABSTRACT
In order to cause the disease anthrax,
Bacillus anthracis
requires two plasmids, pX01 and pX02, which carry toxin and capsule genes, respectively, that are used as genetic targets in the laboratory detection of the bacterium. Clinical, forensic, and environmental samples that test positive by PCR protocols established by the Centers for Disease Control and Prevention for
B. anthracis
are considered to be potentially
B. anthracis
until confirmed by culture and a secondary battery of tests. We report the presence of 10 genes (
acpA
,
capA
,
capB
,
capC
,
capR
,
capD
, IS
1627
, ORF 48, ORF 61, and
repA
) and the sequence for the capsule promoter normally found on pX02 in
Bacillus circulans
and a
Bacillus
species closely related to
Bacillus luciferensis
. Tests revealed these sequences to be present on a large plasmid in each isolate. The 11 sequences consistently matched to
B. anthracis
plasmid pX02, GenBank accession numbers AF188935.1, AE011191.1, and AE017335.3. The percent nucleotide identities for
capD
and the capsule promoter were 99.9% and 99.7%, respectively, and for the remaining nine genes, the nucleotide identity was 100% for both isolates. The presence of these genes, which are usually associated with the pX02 plasmid, in two soil
Bacillus
species unrelated to
B. anthracis
alerts us to the necessity of identifying additional sequences that will signal the presence of
B. anthracis
in clinical, forensic, and environmental samples.
Publisher
American Society for Microbiology
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献